Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking programme that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the programme, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman.
"Menopause has been a new journey for me—one that's changed how I see and care for my body," said Queen Latifah. "It's shown me how important it is for women to have support that truly understands this stage of life. That's why I'm proud to be the spokesperson for WeightWatchers' new programme. For decades, WeightWatchers has helped women live healthier, more confident lives, and now they're once again leading the way with care designed for menopause."
A passionate advocate for women's health, and someone navigating the realities of menopause herself, Queen Latifah brings honesty, empathy, and relatability to a life stage that too long been underserved, lacking both accessible education and personalised care.
WeightWatchers for Menopause combines the best of the brand, with trusted medical care (U.S. only), science-backed nutrition and lifestyle support, and a compassionate community of women—to deliver accessible, personalised care for this stage of life. Developed by leading physicians, menopause specialists, and experts in fitness and nutrition, the programme provides a holistic model designed to meet the distinct nutritional health needs of women from perimenopause to postmenopause. From one-on-one guidance with menopause-trained clinicians and access to evidence-based treatments currently available only in the U.S., to a tailored version of the Points® Programme, fitness designed for strength and stability, and workshops led by coaches who understand this stage of life, the programme offers women everything they need to feel supported, informed, and empowered.
"For more than six decades, WeightWatchers has evolved with the science to meet the changing needs of our members," said Tara Comonte, CEO of WeightWatchers. "With this first-of-its-kind menopause programme we're proud to deliver truly comprehensive care in a single plan, bringing together specialised scientific expertise, science-backed nutrition, lifestyle tools and a compassionate community. This programme sets a new standard for the industry and women's health, empowering millions to feel healthier, stronger, and more confident as they navigate menopause and beyond."
WeightWatchers has a long track record of delivering meaningful results, and this newly launched programme is no exception. In studies, women of menopausal age who followed WeightWatchers' nutritional guidance lost nearly four times more weight than those trying to manage on their own1. For U.S. members seeking additional support, WeightWatchers Clinic has expanded to include clinicians specifically trained in menopause care. These U.S. members receive comprehensive consultations, individualised care plans, and, when appropriate, prescription options such as HRT, GLP-1s, or other evidence-based treatments, all monitored by licensed clinicians. In fact, women of menopausal age enrolled in WeightWatchers Clinic in the U.S. lost on average 18.6% of their body weight in just one year. Emerging research from the Mayo Clinic has found that postmenopausal women receiving hormone therapy in combination with GLP-1 semaglutide achieved approximately 30% greater weight loss than those using the GLP-1 alone.2
"For many women, the changes that come with menopause can feel overwhelming. Hormone-related weight gain in particular often resists traditional methods of weight loss," said Dr. Kim Boyd, Chief Medical Officer of WeightWatchers. "Too often women are left feeling isolated or dismissed because menopause care has been historically overlooked, hard to access, and filled with misinformation. With WeightWatchers for Menopause, we're applying our six decade legacy of supporting women to a specialised curriculum and a trusted community for menopause. We are uniquely positioned to provide women in this stage of life with the guidance and tools they need to achieve real, lasting results."
By bringing together science-backed nutrition and lifestyle change, personalised medical care (U.S. only), and a supportive community, WeightWatchers for Menopause offers the most comprehensive programme of its kind, empowering women to feel healthier, stronger, and more supported as they navigate menopause and beyond with confidence.
For more information or to join WeightWatchers for Menopause, please visit: https://menopause.weightwatchers.co.uk/uk/en/.
Programme availability will roll out in France and Belgium in the coming weeks.
ABOUT WEIGHTWATCHERS
WeightWatchers is the global leader in science-backed weight management, offering an integrated support system that combines scientific expertise and human connection. With more than 60 years of experience, WeightWatchers is the most studied commercial weight management programme in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss programme. Its holistic, personalised approach also includes U.S.-based clinical interventions, medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has surrounded its members with the support they need to reach and sustain their goals, wherever they are on their journey. Members can access these solutions directly, or through WeightWatchers for Business' full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, WeightWatchers offers a proven path forward, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.
___________________________________
1 Based on a secondary analysis of a 6-month randomised controlled trial (n=165 women 45 years or older with complete data) that compared participants following WW to those given standard nutritional guidelines alone. Funded by WW International, Inc.
2 Hurtado, Maria D. MD, PhD1,2; Tama, Elif MD1,2; Fansa, Sima MD2; Ghusn, Wissam MD2; Anazco, Diego MD2; Acosta, Andres MD, PhD2; Faubion, Stephanie S. MD, MBA, MSCP3,4; Shufelt, Chrisandra L. MD, MS, MSCP3,4. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause 31(4):p 266-274, April 2024. | DOI: 10.1097/GME.0000000000002310. Study based on review of records for 1,023 patients between 2021 and 2023.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/66f013c9-af7b-40e8-ae08-f38fad0fefca
For media inquiries, please contact: Kelsey Merkel media@ww.com For investor inquiries, please contact: John Mills or Anna Kate Heller WeightWatchers@icrinc.com
